KRASG12C IN-13 is a selective inhibitor targeting the KRAS G12C mutation. This compound demonstrates significant biological activity against advanced solid tumors, particularly non-small cell lung cancer and colorectal cancer. Researchers can utilize KRASG12C IN-13 to investigate therapeutic strategies and resistance mechanisms associated with KRAS-driven malignancies.
KRASG12C IN-13 is a selective inhibitor targeting the KRAS G12C mutation. This compound demonstrates significant biological activity against advanced solid tumors, particularly non-small cell lung cancer and colorectal cancer. Researchers can utilize KRASG12C IN-13 to investigate therapeutic strategies and resistance mechanisms associated with KRAS-driven malignancies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
